SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.

Coya Therapeutics Inc

Fueled by promising trial results and a strategic partnership with Dr. Reddy's, Coya is trending as the community focuses on its potential to disrupt the neurodegenerative disease space. Discussions revolve around the upcoming Alzheimer's data and the ALS trial, with many speculating about a potential acquisition. The company's novel approach and strong financial position are also driving bullish sentiment.

Targa Resources Corp. engages in the business of gathering, compressing, treating, processing, transporting, and purchasing and selling natural gas. It operates through the following segments: Gathering and Processing, and Logistics and Transportation, and Other. The Gathering and Processing segment includes assets used in the gathering, and purchase and sale of natural gas produced from oil and gas wells. The Logistics and Transportation segment refers to the activities and assets necessary to convert mixed natural gas liquids (NGLs) into NGL products. The Other contains the results of commodity derivative activity mark-to-market gains and losses related to derivative contracts. The company was founded on October 27, 2005 and is headquartered in Houston, TX.

Targa Resources Corp

Targa Resources is trending due to its upcoming inclusion in the S&P 500, replacing Nielsen Holdings. The community is discussing the implications of this move and the company's overall strength in the energy sector. Bullish sentiment is fueled by analyst ratings and potential benefits from increased natural gas demand and strategic positioning in the Permian Basin.

Dynex Capital, Inc. is an internally managed mortgage real estate investment trust. It engages in the business of investing in mortgage-backed securities. The company was founded on December 18, 1987 and is headquartered in Glen Allen, VA.

Dynex Capital, Inc.

Dynex Capital is trending as investors discuss its attractive monthly dividend and potential entry points, with some weighing it against similar REITs. Community members are highlighting the company's consistent dividend payments and solid management team. Broader market volatility and interest rate trends appear to be influencing discussions around DX.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as the community debates recent price action and potential catalysts for future growth. Some traders are pointing to technical indicators suggesting a buying opportunity, while others express concern over governance issues and comparisons to competitors. Discussions also revolve around the broader market impact on Compound's performance.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

MOS is trending due to a recent announcement regarding production interruptions in potash and phosphate, impacting sales volume guidance and spurring community discussion around its effect on the stock. Despite the negative news, some investors view the dip as a buying opportunity, citing the company's strong underlying fundamentals, value, and dividend. Community members also mentioned the potential for long-term gains and a possible rotation into the agriculture sector.

Function is building the financial infrastructure that makes Bitcoin productive, unlocking yield, liquidity, and capital efficiency for holders across DeFi and traditional finance. FBTC turns Bitcoin into an asset that works.  FBTC represents the first omnichain Bitcoin yield asset, enabling BTC holders to participate in structured, risk-managed and programmatic yield strategies. FBTC is fully backed on a 1:1 basis with BTC, Bitcoin Reserve Address List is public and can be verified at any time. FBTC combines the security of Bitcoin reserves with the flexibility of smart contracts, creating a secure and efficient bridge between the Bitcoin network and modern DeFi protocols.  FBTC turns idle BTC into a functional and productive asset. The primary purpose of FBTC is to bring native Bitcoin liquidity into DeFi. Enabling Bitcoin holders to access a wide range of yield generating strategies, without having to sell their BTC. This not only enhances the utility of BTC but also allows holders to earn returns on their assets, making FBTC a powerful tool for maximizing the potential of Bitcoin in the DeFi ecosystem

Function ƒBTC

Function BTC ($FBTC) is trending as the community discusses recent ETF outflows and potential market pullbacks affecting Bitcoin. Optimists view any dip as a buying opportunity, drawing parallels to past recoveries of major tech stocks, while others express concern about macro factors and potential bear cycles. Community members are weighing the impact of potential rate cuts, crypto bills, and the possibility of a Santa Claus rally.

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Sagimet Biosciences Inc - Ordinary Shares - Series A

Sagimet Biosciences Inc

Sagimet Biosciences is trending due to positive Phase 3 acne trial results, sparking community excitement about its potential in the Chinese market and a new mechanism of action. Community members are actively discussing the undervaluation of the stock, potential buyout scenarios, and upcoming catalysts including the KOL event next week. Some are concerned about the absence of news on the mash program and the need for a funding partner.

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending as traders discuss potential entry points based on technical indicators like falling wedge patterns and RSI levels, while some express hesitancy to invest. Community members are also weighing the ETF's outlook against broader market factors, including interest rate cut expectations and housing market data. Bullish sentiment anticipates momentum to continue into the spring, while bearish viewpoints cite concerns about a potential dip into the $30s over the winter.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

BOB is trending as community members highlight its potential as the "new BTC" and its association with the ICP ecosystem, with some suggesting it could outperform ICP. Community discussions also revolve around upcoming halving events and its listing on new platforms like Coinbase, increasing public awareness.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as investors assess its potential in the AI-driven data cloud sector, particularly after recent partnerships and analyst upgrades. Community discussions revolve around its long-term growth prospects and ability to maintain its competitive edge against major players. Bullish sentiment seems to be building around the stock's technical setup and potential for further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Bloomberg reported that the Centers for Medicare &amp; Medicaid Services (CMS), which runs the Medicare program, is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;</li><li>MSOS and YOLO, two key cannabis sector-focused funds, gained 3.4% and 2.7%, respectively.</li><li>The Trump administration seems to be backing cannabis as an industry, following its previous comments regarding CBD and reclassifying marijuana.</li></ul>Cannabis&nbsp;stocks advanced on Wednesday following a report speculating that certain U.S Medicare patients could soon be eligible to receive coverage for CBD under a new initiative.CBD, or cannabidiol, is a compound found in cannabis and used to treat sleep disorders, anxiety, pain, and inflammation. Some research suggests it may also treat cancer symptoms. The drug is sold as gummies, pet treats, and skincare supplements.<h2 class="st-heading-2">Cannabis Stocks Rally</h2>Tilray Brands’ shares rose 4.8%, while the over-the-counter stocks of Curaleaf Holdings, Trulieve Cannabis, and Green Thumb Industries gained between 2% to 5.6%. Shares of Innovative Industrial Properties, a real estate investment trust (REIT) that buys and leases specialized cannabis cultivation facilities, rose 1.1%.On Stocktwits, the retail sentiment for&nbsp;<a href="https://stocktwits.com/symbol/TLRY">TLRY</a> shifted to ‘extremely bullish’ from ‘bullish,’ while that for&nbsp;<a href="https://stocktwits.com/symbol/CURLF">CURLF</a> shifted to ‘bullish’ from ‘neutral.’ The sentiment was ‘bullish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">GTBIF</a>, and ‘bearish’ for&nbsp;<a href="https://stocktwits.com/symbol/GTBIF">TCNNF</a> and&nbsp;<a href="https://stocktwits.com/symbol/IIPR">IIPR</a> as of the last reading.&nbsp;The&nbsp;<a href="https://stocktwits.com/symbol/MSOS">AdvisorShares Pure US Cannabis ETF (MSOS)</a>, which tracks U.S. cannabis companies exclusively, and the&nbsp;<a href="https://stocktwits.com/symbol/YOLO">AdvisorShares Pure Cannabis ETF (YOLO)</a>, which also tracks overseas companies and cannabis-adjacent businesses, rose 3.4% and 2.7%, respectively.<h2 class="st-heading-2">CMS Initaitive</h2>The rally came after Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-26/medicare-to-test-making-cbd-treatment-available-for-seniors">reported</a> that the Centers for Medicare &amp; Medicaid Services (CMS) is planning an initiative that would make some U.S. Medicare patients eligible for CBD coverage.&nbsp;Details of the proposed program aren’t available, but an early version of the plan focused on seniors in oncology and palliative care settings, according to a summary viewed by the news agency.Unnamed sources told Bloomberg that Howard Kessler, a payments financier who has advocated for expanded CBD access, met with Health and Human Services Secretary Robert F. Kennedy Jr. about the issue last month<h2 class="st-heading-2">A Trump Boost?</h2>The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. Hemp-derived cannabidiol (CBD) could "revolutionize senior healthcare" by slowing disease progression and serving as an alternative to prescription drugs, Trump had&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tilray-canopy-growth-cannabis-stocks-lose-high-premarket-after-surge-triggered-by-trumps-post/chDDTJ9R3BB">said</a> in a video post in September.The previous month, Trump said his administration was weighing a move to reclassify marijuana as a less dangerous drug under federal law.That said, doubts over cannabis efficacy in healthcare remain. A&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2836267">recent study</a> funded by the Food and Drug Administration suggested that prolonged use of CBD may cause liver toxicity, while other research suggests it can interfere with other medications, harm male reproductive health, and pose potential risks to children and pregnant women.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/holiday-shopping-could-soar-to-a-record-1-trillion-this-year-with-online-spending-blasting-to-new-highs/cL5eLqVREW6">Holiday Shopping Could Soar To A Record $1 Trillion This Year, With Online Spending Blasting To New Highs</a>

Cannabis plants grow in the greenhouse at Vireo Health's medical marijuana cultivation facility, August 19, 2016 in Johnstown, New York. (Photo by Drew Angerer/Getty Images)

Tilray, IIPR, Trulieve, Other Cannabis Stocks Rally On Report Of Government Considering Adding CBD Treatment For Medicare Patients  

The development comes close on the heels of President Donald Trump highlighting the potential benefits of cannabidiol in senior healthcare. 

Equity

Insider Buying: Innovative Industrial Properties (NYSE:IIPR) Chairman Purchases 2,600 Shares of Stock

Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) Chairman Alan Gold acquired 2,600 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were...

Alan Gold Acquires 2,600 Shares of Innovative Industrial Properties (NYSE:IIPR) Stock

Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) Chairman Alan Gold acquired 2,600 shares of the company's stock in a transaction that occurred on Monday, November 24th. The...

Innovative Industrial Properties, Inc. (NYSE:IIPR) Given Consensus Recommendation of "Reduce" by Analysts

Shares of Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) have been assigned an average recommendation of "Reduce" from the nine ratings firms that are presently covering the...

Innovative Industrial Properties, Inc. $IIPR Shares Sold by LSV Asset Management

LSV Asset Management reduced its holdings in shares of Innovative Industrial Properties, Inc. (NYSE:IIPR - Free Report) by 4.8% during the 2nd quarter, according to its most recent 13F filing with...

AlphaCore Capital LLC Acquires Shares of 209,630 Innovative Industrial Properties, Inc. $IIPR

AlphaCore Capital LLC bought a new position in Innovative Industrial Properties, Inc. (NYSE:IIPR - Free Report) during the second quarter, according to its most recent Form 13F filing with the...

Innovative Industrial Properties (NYSE:IIPR) CFO David Jon Smith Buys 600 Shares

Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) CFO David Jon Smith bought 600 shares of the business's stock in a transaction dated Thursday, November 20th. The shares were...

Alan Gold Purchases 1,000 Shares of Innovative Industrial Properties (NYSE:IIPR) Stock

Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) Chairman Alan Gold acquired 1,000 shares of the business's stock in a transaction that occurred on Wednesday, November 19th. The...

Innovative Industrial Properties (NYSE:IIPR) CFO Buys $27,540.00 in Stock

Innovative Industrial Properties, Inc. (NYSE:IIPR - Get Free Report) CFO David Jon Smith purchased 600 shares of the company's stock in a transaction that occurred on Thursday, November 20th. The...

Innovative Industrial Properties (NYSE:IIPR) Reaches New 12-Month Low - Here's What Happened

Innovative Industrial Properties (NYSE:IIPR) Sets New 52-Week Low - Here's What Happened...

Innovative Industrial Properties, Inc. is a real estate investment trust, which engages in the acquisition, ownership, and management of industrial properties. The firm's property portfolio includes PharmaCann, Inc., SH Parent, Inc., Ascend Wellness Holdings, Inc., Cresco Labs Inc., and Kings Garden Inc. It operates through the following geographical segments: Arizona, California, Colorado, Florida, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Dakota, Ohio, Pennsylvania, Texas, Virginia, and Washington. The company was founded by Alan D. Gold, Gary A. Kreitzer, and Paul E. Smithers on June 15, 2016 and is headquartered in Park City, UT.

Innovative Industrial Properties Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

IIPR
Innovative Industrial Properties Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IIPR News

IIPRInnovative Industrial Properties Inc